Home / Import refusals / SCS-3621753-0/11/3

FDA Import Refusal SCS-3621753-0/11/3 — Bausch Health Companies Inc.

Bausch Health Companies Inc. — FEI 3002806613

The FDA refused shipment SCS-3621753-0/11/3 from Bausch Health Companies Inc. (Canada) on September 20, 2022. The refused product falls under Drugs and Biologics — BUPROPION HCL (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 20, 2022
Country
Canada
Product Category
Drugs and Biologics
Product Code
61NCA05 BUPROPION HCL (ANTI-DEPRESSANT)
Charges
75

Recent inspections

  • 1207309 (NAI Fri May 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1057827 (NAI Fri May 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 991127 (NAI Fri Sep 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886644 (NAI Fri May 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 770131 (NAI Thu Mar 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0272725-2/10002/1 (Thu Apr 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8958101-4/20003/1 (Mon Dec 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-7206171-9/10003/1 (Fri Nov 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-8529827-4/10003/1 (Mon Nov 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • EI5-5600896-6/10002/1 (Fri Nov 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources